title: Neuroleptic malignant syndrome: liability in nursing practice.
abstract: In the summer of 1991, the malpractice case Reyes v Houston International Hospital et al was settled for an amount in excess of $600,000. The case involved the psychiatric treatment received by Marjorie Reyes, a 27-year-old Latin-American mother of three, who was admitted to a psychiatric unit in late October 1986 with a diagnosis of atypical psychosis. Malpractice was charged because her treatment failed to meet any reasonably expected outcome for atypical psychosis. In fact, Reyes developed neuroleptic malignant syndrome (NMS) as a direct result of the antipsychotic medications she was administered. Her treatment outcome was nearly fatal and caused permanent, serious neurological disabilities. The litigation implicated the nursing care delivered in a psychiatric setting. This unfortunate situation illustrates general principles of legal liability in nursing practice as well as offers a unique opportunity to review NMS and to examine the specific implications for the assessment and evaluation of the side effects of antipsychotic medications. Additionally, methods of behavioral control, specifically as they relate to concepts concerning the use of medications, the importance of documentation, and the manner in which nurses plan care, were also addressed in the case. It is important for professionals to be familiar with general legal concepts and liabilities, the potential of the development of this serious side effect, and how clinical decisions regarding the administration of both routine and as-needed medications may incur legal accountability.
authors.affiliation: Extended Care Psychiatry, Commery-O'Neil VA Medical Center, Topeka, Kansas.
authors.forename: D T
authors.initials: DT
authors.lastname: Blair
authors.forename: A
authors.initials: A
authors.lastname: Dauner
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001925:Brain Damage, Chronic / Q000139:chemically induced / Q000451:nursing; D004305:Dose-Response Relationship, Drug; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D016365:Liability, Legal; D008318:Malpractice / Q000331:legislation & jurisprudence*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000451:nursing; D011568:Psychiatric Nursing / Q000331:legislation & jurisprudence*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects*; D013888:Thiothixene / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D013888:Thiothixene; D006220:Haloperidol